Professional Documents
Culture Documents
Neuromonitoring 2014pdf
Neuromonitoring 2014pdf
Neuromonitoring
Indications and Utility in
the Intensive Care Unit
CATHERINE HARRIS, PhD, MBA, CRNP
Information on the use of neuromonitoring in intensive care units is scattered but significant. Nurses who do
not care for neurologically impaired patients on a daily basis may not have a strong understanding of the util-
ity of various neuromonitoring techniques, why they are used, or how they are interpreted. Two main types of
neuromonitoring that are frequently seen but poorly understood are reviewed here: transcranial Doppler sono-
graphy and electrophysiology. Information on these 2 techniques tends to be either superficial with limited
applicability to the critical care setting or very technical. This review provides information about neuromoni-
toring to help guide critical care nurses providing care to neurologically impaired patients. {Critical Care Nurse.
2014;34[3]:30-40)
euromonitoring is an umbrella term used to describe the various invasive and nonin-
N vasive techniques that are available for monitoring functioning of the central nervous
system. Neuromonitoring techniques are essential tools used in evaluating patients with neu-
rological injury in critical care settings. Neuromonitoring is typically used when a clinical neurological
examination is either difficult or not practical to perform, such as during an operative procedure or
when the patient's mental status has deteriorated. Depending on the technique used, neuromonitoring
allows the health care staff to evaluate motor and sensory function, brain activity, blood fiow, and
intracranial pressures. Nurses must be able to use various neuromonitoring techniques and interpret
their results to provide the best care for their patients. However, useful and user-friendly information
on the indications and utility of neuromonitoring is scarce. In this article, I review 2 pertinent types of
noninvasive neuromonitoring techniques encountered in intensive care units, transcranial Doppler
monitoring and electrophysiology, for their indications, use, and applicability to patient care. Invasive
monitoring such as intracranial monitoring is not covered here.
This article has been designated for CNE credit, A closed-book, multiple-choice examination follows this article, which tests your knowledge
of the following objectives:
1, Describe neuromonitoring with transcranial Doppler monitoring and electrophysiology for the neurologically impaired patients
2, Identify normal and abnormal findings with transcranial Doppler monitoring and electrophysiology
3, Discuss the indications, use, and applicability of transcranial Doppler monitoring and electroencephalography in the neurocritical patient
Temporal window
MCA
Transorbltai
ACA, PCA
window:
ICA
Ophthainnic artery
Reprinted trom Scheil et ai,' witb kind permission trom Springer Science+Business Media B.V,
Label Depth Mean Peak Edv PI Rl Label Depth Mean Peak Edv PI Rl
2 MHz
L-EX-ICA 50 -24,6 -58,1 -14,9 1,73 0,74 R-EX-ICA 50 -23,5 -56,2 -4,21 2,21 0,91
L-EX-ICA 52 -23,5 -52,4 -14,2 1,61 0,72 R-EX-ICA 50 -22,7 -60,1 -4,17 2,40 0,92
L-OA 50 19,6 39,7 6,17 1,64 0,81 R-EX-ICA 52 -25,4 -69,3 -7,50 2,39 0,88
L-Siphon 60 32,7 62,8 18,1 1,34 0,71 R-OA 50 18,1 36,2 4,39 1,72 0,87
-20.4 -43,1 -5,87 1,68 0,77 R-OA 50 21,2 38,1 5,45 1,52 0,85
L-Siphon 60 25,4 53,5 7,09 1,79 0,85 R-Siphon 66 36,2 65,8 14,2 1,39 0,77
L-MCA 50 55,8 115 34,6 1.43 0,69 R-VA 60 -20,0 -34,6 -7,28 1,28 0,76
L-MCA 52 64.3 137 39,8 1,51 0,71 R-VA 62 -25,8 -65,8 -4,56 2,33 0,92
L-MCA 56 61,2 132 38,5 1,51 0,70 R-VA 66 -16,6 -57,4 -3,99 3,09 0,91
L-MCA 58 70,1 139 45,4 1,32 0,67 R-VA 66 -15,8 -58,9 -3,62 3,17 0,91
L-MCA 58 68.1 142 43,2 1,44 0,69 R-VA 66
L-MCA 58 73,2 139 46.6 1,26 0,66 R-MCA 50 42,7 89,3 25,4 1,47 0,71
L-MCA 58 62,8 133 39,1 1,48 0,70 R-MCA 52 33,9 69,3 14,5 1,58 0,78
L-MCA 58 70,8 139 44,1 1,33 0,68 R-MCA 54 40,8 79,7 22,3 1,39 0,71
L-MCA 60 66,6 134 44,3 1,34 0,67 R-MCA 54 55,8 104 29,0 1,29 0,70
L-MCA/ACA 66 71,6 184 44.1 1,95 0,75 R-MCA 54 65,8 131 41,2 1,34 0,68
-40,8 -67,4 -25,1 1,02 0,62 R-MCA 58 65,8 167 37,0 1,95 0,77
L-MCA/ACA 66 61,2 161 37,2 2,00 0,74 R-MCA/ACA 64 43,5 82,0 28,9 1,21 0,64
-40.0 -72,8 -25,9 1,16 0,62 -50,8 -97,4 -30,5 1,30 0,68
L-ACA 66 -42,4 -72,0 -28,0 1,03 0,57 R-MCA/ACA 66 46,6 85,5 26,6 1,20 0,66
L-ACA 66 -44,3 -77,8 -28,9 1,09 0,59 -37,0 -67,0 -20,4 1,23 0,68
L-ACA 70 -44,7 -80,1 -30,7 1,09 0,61 R-ACA 70 -43,1 -87,0 -27,4 1,36 0,68
L-T-ICA 50 23,1 62,0 3,05 2.50 0,94 R-ACA 68 -39,7 -75,5 -24,6 1,27 0,67
L-PCA P1 70 43,9 70,8 20,7 1,11 0,68 R-MCA 50 64,7 146 37,5 1,66 0,72
L-PCA P1 70 46,2 68,5 25,4 0,91 0,62 R-MCA 56 75,1 138 48,8 1,18 0,64
L-PCA P1 68 43,5 72,0 23,4 1,10 0,67 R-MCA 56 73,9 144 44,7 1,33 0,68
L-VA 60 -26,2 -76.6 -9,41 2,32 0.60 R-T-ICA 56 20,0 45,4 4,71 2,00 0,89
L-VA 64 -20,0 -30,4 -12,4 0,89 0,58 R-T-ICA 56 23,5 54,7 4,97 2,02 0,87
L-VA 60 -21,9 -31,2 -15,8 0,69 0,49 R-PCA P1 56 18,1 45,0 2,61 2,28 0,92
L-VA 64 -21,2 -30,0 -14,6 0,72 0,51 R-PCA P1 64 22,7 40,8 13,3 1,19 0,66
L-VA 66 -20,4 -32,0 -12,8 0,92 0,59 R-PCA P1 66 21,9 41,6 12,6 1,30 0.68
L-VA 66 -21,2 -31,2 -14,4 0,78 0,53 R-PCA P1 72 20,0 45,4 6,74 1,80 0,79
T a b l e 5 Frequency bands^
• " \ "
.••'.•V-V--1V '•Af.'-'..'-••"•.•
"/•• .'vA-^"'
Status epileptícus
Burst suppression
/I
Brain death
cali from the epileptologist who is monitoring the patient providers will typically ask the nurses to titrate the med-
for clarification. ications to a certain number of bursts per minute. For
Burst suppression is evidenced by voltage attenua- example, in an induced coma, the order may read to
tion with bursts of generalized activity. Burst suppres- titrate either a pentobarbital or propofol infusion to 4 to
sion is seen in clinical states such as anoxic brain injury 6 bursts per minute. If a standard EEG screen displays 15
or prolonged resuscitation or it can be induced with seconds of information, the nurse should see a minimum
medications such as pentobarbital or propofol. When of 1 burst of electrical activity on the screen at any given
burst suppression is pharmacologically induced. time, but no more than 2. An accurate assessment of
Harris C. Neuromonitoring Indications and Utility in the Intensive Care Unit. Critical Care Nurse. 2014;34(3):30-40.
1. Which of the following is an experimental use of transcranial Doppler 7, Which of the following is not a derivative of electroencephalography (EEG)?
(TCD) imaging? a, Bispectral monitoring
a. Assessment for collateral flow patterns b, Somatosensory evoked potentials
b. Assessment for cerebral blood flow c, Brainstem auditory evoked potentials
c. Detection of cerebral emboli d, Transcutaneous nerve stimulation
d. Evaluation of arteriovenous malformations
8, An EEG is the evaluation of spontaneous electrical activity in the brain
?.. Which of the following is not a cranial window for TCD monitoring? used to guide which of the following?
a. Temporal a. Nutritional management
b. Orbital b. Seizure management
c. PariPtal c. Vasopressor therapy
d. Occipital d. Hypothermia therapy
3. Which of the following velocities are established as the criterion to follow 9, Which of the following are the typical markings of status epilepticus on
to assess blood flow in the brain? the EEG?
a. Meanflowvelocity a. Amplitude spikes
b. Peak now velocity b. Latency spikes
c. Modeflowvelocity c. Frequency spikes
d. Median flow velocity d. Delta spikes
4, A significant decrease in mean flow velocity may reflect which of the 10, What can an EEG help diagnose when there is cessation of any activity?
following complications? a. Level of sedation
a. Increasing severity of vasospasm b. Brain death
b. Impending or competed stroke c. Level of anesthesia
c. Increasing severity of hyperemia d. Brain hypoxia
d. Rupture of a cerebral aneurysm
11, What does the bispectral monitoring device indicate if the index range
5, The Lindegaard ratio examines the mean flow velocity in which of the number is 20-40?
following? a. Awake
a. Middle cerebral artery divided by the mean flow velocity in the ipsilateral b. Light to moderate sedation
internal carotid artery (ICA) c. General anesthesia
b. Anterior cerebral artery divided by the mean flow velocity in the ipsilateral d. Burst suppression
ICA
c. Posterior cerebral artery divided by the mean flow velocity in the ipsilat- 12, Brainstem auditory evoked potentials may show signal changes when the
eral ICA patient s intracranial pressure is at what level?
d. Basilar cerebral artery divided by the meanflowvelocity in the ipsilateral ICA a, 15-19 mm Hg
b, 20-24 mm Hg
6. A Lindegaard ratio of >3-6 indicates which degree of vasospasm severity? c, 25-29 mm Hg
a. None d, >30 mm Hg
b. Mild
c. Moderate
d. Severe
Test answers: Mark only one box for your answer to each question. You may photocopy this form,
.•a 2. Qa 3. üa 4.aa 5. Qa ó.^a l.Qa 8.aa 9.aa 10. Qa 11. Qa 12. Q a
•b üb Qb Qb Ub Uh Ub Qb Qb Qb üb Ub
•c Qc Qc Qc ac ac üc ac Qc Qc Qc Qc
•d ad Qd Qd Qd Qd Dd Qd Ud Qd Qd Qd
Test ID: C143 Form expires: June 1, 2017 Contact hours: 1,0 Pharma hours: 0,0 Fee: AACN members, $0; nonmembers, $10 Passing score: 9 correct (75%)
Synergy CERP Category A Test writer: Lynn C, Simko, PhD, RN, CCRN